TY - JOUR
AU1 - Halliburton, Cory S.
AU2 - Mannino, David M.
AU3 - Olney, Richard S.
AB - Abstract Objective: To analyze mortality trends among people who died with a diagnosis of cystic fibrosis from January 1, 1979, through December 31, 1991. Methods: We reviewed death certificate reports in the Multiple-Cause Mortality Files compiled by the National Center for Health Statistics. Results: Of the 26 866 600 decedents in the study period, 6500 had a diagnosis of cystic fibrosis listed on their death certificates; of these, 6014 (92.5%) had cystic fibrosis listed as the underlying cause of death. The ageadjusted mortality rate decreased 21%, from 2.4 per 1 million in 1979 to 1.9 per 1 million in 1991, with similar decrements among males and females. The median age of death increased from 15 years in 1979 to 23 years in 1991. During the study period, whites were 6 times more likely to die with a diagnosis of cystic fibrosis than were blacks, and 8 times more likely than were people of other races. Comorbid conditions mentioned on death certificates included obstructive lung disease in 744 (11.5%), pneumonia in 1192 (18.3%), and right heart failure in 986 (15.2%). Conclusions: From 1979 through 1991, the ageadjusted mortality rate for cystic fibrosis decreased and the median age of death among decedents with a diagnosis of cystic fibrosis increased. These results probably are due to improved treatment of the disease in children, although we cannot exclude other explanations for these findings, such as changes in death certification and coding or better diagnosis of the disease.Arch Pediatr Adolesc Med. 1996;150:1181-1185 References 1. FitzSimmons SC. The changing epidemiology of cystic fibrosis . CurrProbl Pediatr . 1994;24:171-179. 2. Hill DJS, Martin AJ, Davidson GP, Smith GS. Survival of cystic fibrosis patients in South Australia . Med J Aust . 1985;143:230-232. 3. Wesley AW, Stewart AW. Cystic fibrosis in New Zealand: incidence and mortality . N Z Med J . 1985;98:321-323. 4. Macri CN, de Gentile AS, Manterola A, et al. Epidemiology of cystic fibrosis in Latin America: preliminary communication . Pediatr Pulmonol . 1991;10:249-253.Crossref 5. US Congress Office of Technology Assessment. Cystic Fibrosis and DNA Tests: Implications of Carrier Screening. Washington, DC: US Congress Office of Technology Assessment; 1992:1-2. Publication 052-003-01291-0. 6. Sharples L, Hathaway T, Dennis C, Caine N, Higenbottam T, Wallwork J. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation . J Heart Lung Transplant . 1993;12:669-674. 7. Corey M, McLaughlin FJ, Williams M, Levinson H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto . J Clin Epidemiol . 1988;41:583-591.Crossref 8. Wood RE, Boat TF, Doershuk CF. State of the art: cystic fibrosis . Am Rev Respir Dis . 1976;113:833-878. 9. Super M. Milestones in cystic fibrosis . Br Med Bull . 1992;48:717-737. 10. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis . N Engl J Med . 1992;326:1187-1191.Crossref 11. Durie PR. Cystic fibrosis: gastrointestinal and hepatic complications and their management . Semin Pediatr Gastroenterol Nutr . 1993;4:3-9. 12. Williams SG, Hayller KM, Hodson ME, Westaby D. Prognosis in cystic fibrosis . N Engl J Med . 1992;327:1244-1245. 13. Arekart-Treichel J. Lengthened survival raises problems in cystic fibrosis . JAMA . 1984;252:2526-2527.Crossref 14. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000 . Thorax . 1991;46:881-885.Crossref 15. Nielson OH, Thomsen BL, Green A, Anderson PK, Hauge M, Schiotz PO. Cystic fibrosis in Denmark 1945 to 1985: an analysis of incidence, mortality and influence of centralized treatment on survival . Acta Paediatr Suppl . 1988:77: 836-841.Crossref 16. Beaudet AL, Buffone GJ. Prenatal diagnosis of cystic fibrosis . J Pediatr . 1987; 111:630-633.Crossref 17. Mellis CM. Cystic fibrosis . Med J Aust . 1985;143:227-228. 18. Samuelson WM. Cystic fibrosis: a newer outlook . Medicine (Baltimore) . 1995; 74:58-61.Crossref 19. Evensen SA. A 69-year-old man with chronic obstructive pulmonary disease, pancreatic insufficiency and elevated sweat electrolytes . Acta Med Scand . 1981; 209:141-143.Crossref 20. Brown RF, DiBenedetto R, Russell D, Su C. Variant cystic fibrosis in an elderly man . South Med J . 1986;79:1430-1432.Crossref 21. Spencer DA, Venkatamaran M, Higgins S, Stevenson K, Weller PH. Cystic fibrosis in children from ethnic minorities in the West Midlands . Respir Med . 1994;88:671-675.Crossref 22. Shwachman H, Kowalski M, Khaw K-T. Cystic fibrosis, a new outlook: 70 patients above 25 years of age . Medicine . 1977;74:48-58.Crossref 23. Miller RW. Digestive-tract cancer in cystic fibrosis . J Pediatr . 1993;123:172.Crossref 24. Neglia JP, Fitzsimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis . N Engl J Med . 1995;332:494-499.Crossref 25. Addy DP. Cystic fibrosis: current survival and population estimates to the year 2000 . Thorax . 1992;47:327-328.Crossref
TI - Cystic Fibrosis Deaths in the United States From 1979 Through 1991: An Analysis Using Multiple-Cause Mortality Data
JF - Archives of Pediatrics & Adolescent Medicine
DO - 10.1001/archpedi.1996.02170360071012
DA - 1996-11-01
UR - https://www.deepdyve.com/lp/american-medical-association/cystic-fibrosis-deaths-in-the-united-states-from-1979-through-1991-an-ec00u0xhiz
SP - 1181
EP - 1185
VL - 150
IS - 11
DP - DeepDyve
ER -